World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
14020
World Ranking
13669
National Ranking
286

Jan van Lunzen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Jan van Lunzen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 166 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Jan van Lunzen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jan van Lunzen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Jan van Lunzen is affiliated with ViiV Healthcare in Spain. Their research spans multiple areas within medicine, with a focus on immunology and microbiology. The primary fields of study include Medicine, represented in 34 publications, and Immunology and Microbiology, with 18 publications. Within these areas, van Lunzen has contributed significantly to subfields such as Virology, Infectious Diseases, Epidemiology, Immunology, and Emergency Medicine.

The scientist's work emphasizes topics related to HIV and associated health complications. Major research subjects comprise:

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Cytomegalovirus and herpesvirus research
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment

Van Lunzen has published in several journals and venues, with frequent contributions to:

  • Frontiers in Immunology (4 publications)
  • AIDS (2 publications)
  • Open Forum Infectious Diseases (2 publications)
  • Nature Medicine (1 publication)
  • JCI Insight (1 publication)

Their recent papers include:

  • "Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021" (2021, Nature Medicine)
  • "Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis" (2021, AIDS)
  • "Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells" (2021, JCI Insight)
  • "Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1" (2020, Science Translational Medicine)
  • "The 2000HIV study: Design, multi-omics methods and participant characteristics" (2022, Frontiers in Immunology)

Frequent co-authors in van Lunzen's research include:

  • Leo A. B. Joosten
  • W Vos
  • Albert L. Groenendijk
  • Marc J. T. Blaauw
  • Louise E. van Eekeren

Best Publications

  • Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

    Alison J. Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

    Bonaventura Clotet;Judith Feinberg;Jan Van Lunzen;Marie Aude Khuong-Josses

  • Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

    Roberto Ortiz;Edwin DeJesus;Homayoon Khanlou;Evgeniy Voronin

  • Expansion of HIV-specific T follicular helper cells in chronic HIV infection.

    Madelene Lindqvist;Jan van Lunzen;Damien Z. Soghoian;Bjorn D. Kuhl

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy.

    Linqi Zhang;Sharon R. Lewin;Martin Markowitz;Hsi-Hsun Lin

  • Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

    Christoph Lange;Ibrahim Abubakar;Jan Willem C. Alffenaar;Graham Bothamley

  • Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

    Jan van Lunzen;Franco Maggiolo;José R Arribas;Aza Rakhmanova

  • Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

    Anthony Mills;Jose R. Arribas;Jaime Andrade-Villanueva;Giovanni DiPerri

  • Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

    Christine Katlama;Steven G Deeks;Brigitte Autran;Javier Martinez-Picado

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

    Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

  • MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands

    Angela Meier;Galit Alter;Nicole Frahm;Harlyn Sidhu

  • The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy.

    Klara Tenner-Racz;Hans-Jürgen Stellbrink;Jan van Lunzen;Claus Schneider

  • Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

    Jean Michel Molina;Bonaventura Clotet;Jan van Lunzen;Adriano Lazzarin

  • Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.

    V Miller;A Mocroft;P Reiss;C Katlama

  • Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

    Christoph Wyen;Heidy Hendra;Martin Vogel;Christian Hoffmann

  • Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

    Julian Schulze zur Wiesch;Julian Schulze zur Wiesch;Adriana Thomssen;Adriana Thomssen;Philip Hartjen;Philip Hartjen;Ilona Tóth;Ilona Tóth

  • Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus.

    Jan van Lunzen;Tobias Glaunsinger;Ingrid Stahmer;Volker von Baehr

  • Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection.

    Norma Jung;Clara Lehmann;Andrea Rubbert;Meike Knispel

  • Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

    Roger Paredes;Amanda Mocroft;Ole Kirk;Adriano Lazzarin

Frequent Co-Authors

Gerd Fätkenheuer
Gerd Fätkenheuer University of Cologne
Marcus Altfeld
Marcus Altfeld University Medical Center Hamburg-Eppendorf
Jürgen K. Rockstroh
Jürgen K. Rockstroh University Hospital Bonn
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Joachim Hauber
Joachim Hauber Heinrich-Pette-Institute
Bruce D. Walker
Bruce D. Walker Harvard University
Amanda Mocroft
Amanda Mocroft University College London
Ansgar W. Lohse
Ansgar W. Lohse Universität Hamburg
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open doors to diverse, rewarding careers in healthcare and life sciences. If you’re seeking flexible learning options or wish to complement your primary studies, numerous affordable online programs can help you gain specialized knowledge and skills.

For those interested in data management within healthcare settings, a bachelor's degree health information management provides a strong foundation in organizing, handling, and protecting patient health data. This path blends healthcare knowledge with information technology, meeting a critical demand in today’s medical industry.

If nutrition and wellness inspire you, an online master's degree in nutrition can enhance your scientific understanding and lead to careers as a nutritionist, educator, or consultant. For those interested in diagnostic imaging, online sonography certificate programs and online radiology tech programs offer direct pathways into rapidly growing health tech fields.

These online degrees offer flexible options to expand your career prospects, deepen your expertise, or transition into new roles related to Biology and Biochemistry.

Best Scientists Citing Jan van Lunzen

Trending Scientists

Recently Published Articles